Levonorgestrel
Who holds supplier records for Levonorgestrel? 14 organisations hold a current record for Levonorgestrel: an active US FDA Type II Drug Master File or a CEP. A further 6 organisations have only historical (inactive) DMF filings. 7 of them hold a valid EU Certificate of Suitability (8 holder entries on the EDQM register, listed below). Recorded organisation countries for current records: India (4), China (3), Taiwan (2), Germany (1) and 3 other countries (3); not recorded for 1.
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Levonorgestrel: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/levonorgestrel
Reading the evidence
- 14 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- 10 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
- US product patents listed
The latest patent listed in the FDA Orange Book for an approved product containing Levonorgestrel expires 7 Sept 2040. Product, formulation and method-of-use patents do not by themselves stop the ingredient being supplied or other products being approved.
Current records (14)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Levonorgestrel. Country is the organisation's recorded country, not necessarily the manufacturing site.
- Bayer AGGermanyCEP Company GMP cert on recordActive DMF 4178 · latest filing May 1981
- Gedeon RichterHungaryCEP Company GMP cert on recordActive DMF 8806 · latest filing Oct 1990
- Hubei Gedian Humanwell Pharmaceutical Co. LtdChinaCEP Company GMP cert on recordActive DMF 33000 · latest filing Jun 2022
- INDUSTRIALE CHIMICA SRLItalyCEP Company GMP cert on recordActive DMF 16696 · latest filing Jul 2003
- Lupin LimitedIndiaCEP Company GMP cert on recordActive DMF 22508 · latest filing Mar 2009
- QINHUANGDAO ZIZHU PHARMACEUTICAL CO LTDChinaCEPActive DMF 27692 · latest filing Oct 2013
- STERLING CHEMICAL MALTA LTDMaltaCEP Company GMP cert on recordActive DMF 28502 · latest filing Aug 2014
- Cipla LimitedIndia Company GMP cert on recordActive DMF 21547 · latest filing Jul 2008
- Formosa Laboratories, Inc.Taiwan Company GMP cert on recordActive DMF 21634 · latest filing May 2008
- Hunan KYF Pharmaceutical. Co., LtdChinaActive DMF 37443 · latest filing Sept 2022
- SCINOPHARM TAIWAN LTDTaiwanActive DMF 17067 · latest filing Dec 2003
- SYMBIOTEC PHARMALAB PRIVATE LTDIndia Company GMP cert on recordActive DMF 27867 · latest filing Jan 2014
- VALARY LAB PRIVATE LIMITEDIndia Company GMP cert on recordActive DMF 42141 · latest filing Jul 2025
- ZHEJIANG XIANJU PHARMACEUTICAL CO LTDActive DMF 42874 · latest filing Nov 2025
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Valid CEP holder entries (8)
Certificates of Suitability on the EDQM register for Levonorgestrel, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 14 certificates in total, including withdrawn, expired, suspended and repeat certificates.
| Holder | Country | Certificate | Issued | EU GMP at holder's address |
|---|---|---|---|---|
| GEDEON RICHTER PLC. Budapest X | HU | CEP 2026-245 - Rev 00 Levonorgestrel, Micronised - Dorog site | Jun 2026 | Inspected Jun 2026 Hungary |
| INDUSTRIALE CHIMICA S.R.L. Saronno | IT | CEP 2025-476 - Rev 00 Levonorgestrel, Process 2 | Dec 2025 | Inspected Oct 2025 Italy |
| HUBEI GEDIAN HUMANWELL PHARMACEUTICAL CO., LTD. Ezhou City | CN | CEP 2022-199 - Rev 01 Levonorgestrel, Non-micronised and micronised | Nov 2025 | Inspected Nov 2023 Germany |
| QINHUANGDAO ZIZHU PHARMACEUTICAL CO., LTD. Qinhuangdao City | CN | CEP 2022-225 - Rev 02 Levonorgestrel, Micronised, Process II | Oct 2025 | — |
| LUPIN LIMITED Mumbai | IN | CEP 2012-349 - Rev 01 Levonorgestrel | Sept 2024 | — |
| STERLING CHEMICAL MALTA LTD. Birzebbugia | MT | R0-CEP 2021-255 - Rev 01 Levonorgestrel, Micronised, code 200318 | Jun 2023 | — |
| GEDEON RICHTER PLC. Budapest | HU | R1-CEP 1999-141 - Rev 04 Levonorgestrel | Dec 2021 | — |
| BAYER AG Leverkusen | DE | R1-CEP 2000-101 - Rev 03 Levonorgestrel, Micro 20 | Mar 2017 | — |
The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.
Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.
Historical records (6)
Organisations whose Type II DMFs for Levonorgestrel are no longer active. These show a past filing, not current supply.
Show all 6 historical records
- INDO PHYTO CHEMICALS PRIVATE LTDInactive DMF 26064 · filed May 2012
- BAYER PHARMA AGInactive DMF 18403 · filed Jun 2005
- HOECHST MARION ROUSSEL SAInactive DMF 14288 · filed Jul 1999
- HUBEI PHARMACEUTICAL FACTORYInactive DMF 12994 · filed May 1998
- YANGZHOU PHARMACEUTICAL FACTORYInactive DMF 12934 · filed Mar 1998
- Finland · Inactive DMF 10218 · filed May 1993
US product patents and exclusivity
The FDA Orange Book lists patents and exclusivities for specific approved products (18 listed products contain Levonorgestrel). The latest listed patent expires 7 Sept 2040. The latest listed exclusivity ended 29 Jun 2026. These dates are product-specific: they can cover a formulation, a combination or a method of use, and do not on their own show whether the ingredient is protected or whether generics are already approved. Check the individual product entries before planning a launch.
Overview
Levonorgestrel is a synthetic progestogen used in various hormonal contraceptives, including emergency contraceptive pills. It works by preventing ovulation and fertilization of an egg.
Chemical identity
- IUPAC name
- (8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
- Canonical SMILES
- CC[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C#C)O)CCC4=CC(=O)CC[C@H]34
- InChIKey
- WWYNJERNGUHSAO-XUDSTZEESA-N
- Synonyms
- Plan B API, afirmelle component levonorgestrel, alesse component levonorgestrel, altavera component levonorgestrel, aviane component levonorgestrel, bay86-5028, climara pro component levonorgestrel, elifemme component levonorgestrel, enpresse component levonorgestrel, fallback solo, implant with levonorgestrel, introvale component levonorgestrel
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Progestin; Progestin-containing Intrauterine Device; Progestin-containing Intrauterine System
- Physiologic effect
- Inhibit Ovum Fertilization
- Chemical structure
- Progesterone Congeners
Therapeutic areas
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Levonorgestrel?
14 organisations hold an active US FDA Type II Drug Master File or a CEP for Levonorgestrel: Bayer AG (Germany), Gedeon Richter (Hungary), Hubei Gedian Humanwell Pharmaceutical Co. Ltd (China), INDUSTRIALE CHIMICA SRL (Italy), Lupin Limited (India), QINHUANGDAO ZIZHU PHARMACEUTICAL CO LTD (China), STERLING CHEMICAL MALTA LTD (Malta) and Cipla Limited (India), and 6 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Levonorgestrel Drug Master Files are active?
Bayer AG (DMF 4178), Gedeon Richter (DMF 8806), Hubei Gedian Humanwell Pharmaceutical Co. Ltd (DMF 33000), INDUSTRIALE CHIMICA SRL (DMF 16696), Lupin Limited (DMF 22508), QINHUANGDAO ZIZHU PHARMACEUTICAL CO LTD (DMF 27692), STERLING CHEMICAL MALTA LTD (DMF 28502) and Cipla Limited (DMF 21547) and 6 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Levonorgestrel records mean?
6 organisations have only inactive Type II DMFs for Levonorgestrel. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
Does Levonorgestrel have a European Certificate of Suitability?
Yes. 7 organisations hold a valid CEP for Levonorgestrel on the EDQM register, including GEDEON RICHTER PLC. Budapest X (HU), INDUSTRIALE CHIMICA S.R.L. Saronno (IT), HUBEI GEDIAN HUMANWELL PHARMACEUTICAL CO., LTD. Ezhou City (CN), QINHUANGDAO ZIZHU PHARMACEUTICAL CO., LTD. Qinhuangdao City (CN), LUPIN LIMITED Mumbai (IN) and STERLING CHEMICAL MALTA LTD. Birzebbugia (MT) and 2 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
Does the FDA Orange Book list patents for products containing Levonorgestrel?
Yes. The latest patent listed for an approved US product containing Levonorgestrel expires 7 Sept 2040, across 18 listed products. These patents protect specific products, formulations or uses. They do not by themselves mean the ingredient is protected, and generic versions of other products may already be approved.
How do I qualify a Levonorgestrel supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Levonorgestrel?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.